Jeff Yass’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $25.1M | Buy |
357,774
+302,934
| +552% | +$15.7M | ﹤0.01% | 2212 |
|
|
2026
Q1 | $2.79M | Sell |
54,840
-1,560,559
| -97% | -$72.8M | ﹤0.01% | 5422 |
|
|
2025
Q4 | $47.6M | Sell |
1,615,399
-343,295
| -18% | -$9.33M | 0.01% | 1405 |
|
|
2025
Q3 | $50.6M | Sell |
1,958,694
-890,418
| -31% | -$24.8M | 0.01% | 1334 |
|
|
2025
Q2 | $78.6M | Buy |
2,849,112
+1,620,401
| +132% | +$42.7M | 0.01% | 891 |
|
|
2025
Q1 | $34.8M | Sell |
1,228,711
-894,997
| -42% | -$31.8M | 0.01% | 1256 |
|
|
2024
Q4 | $88.3M | Buy |
2,123,708
+815,129
| +62% | +$39M | 0.01% | 792 |
|
|
2024
Q3 | $87.5M | Buy |
1,308,579
+1,089,765
| +498% | +$100M | 0.02% | 714 |
|
|
2024
Q2 | $26M | Buy |
218,814
+4,183
| +2% | +$529K | ﹤0.01% | 1472 |
|
|
2024
Q1 | $22.9M | Sell |
214,631
-224,975
| -51% | -$22.7M | ﹤0.01% | 1648 |
|
|
2023
Q4 | $43.7M | Buy |
439,606
+107,579
| +32% | +$9.05M | 0.01% | 1125 |
|
|
2023
Q3 | $34.3M | Sell |
332,027
-202,372
| -38% | -$22.6M | 0.01% | 1269 |
|
|
2023
Q2 | $64.9M | Buy |
534,399
+253,789
| +90% | +$33.9M | 0.01% | 834 |
|
|
2023
Q1 | $43.1M | Sell |
280,610
-31,802
| -10% | -$5.25M | 0.01% | 1044 |
|
|
2022
Q4 | $56.1M | Sell |
312,412
-404,328
| -56% | -$66.1M | 0.01% | 823 |
|
|
2022
Q3 | $84.8M | Buy |
716,740
+343,125
| +92% | +$52.1M | 0.02% | 553 |
|
|
2022
Q2 | $53.4M | Sell |
373,615
-114,180
| -23% | -$16.3M | 0.01% | 821 |
|
|
2022
Q1 | $84M | Buy |
487,795
+354,840
| +267% | +$59.7M | 0.01% | 734 |
|
|
2021
Q4 | $33.8M | Sell |
132,955
-568,255
| -81% | -$166M | 0.01% | 1386 |
|
|
2021
Q3 | $270M | Buy |
701,210
+547,724
| +357% | +$202M | 0.04% | 406 |
|
|
2021
Q2 | $36.1M | Sell |
153,486
-845,048
| -85% | -$151M | 0.01% | 1446 |
|
|
2021
Q1 | $131M | Buy |
998,534
+296,592
| +42% | +$43M | 0.02% | 601 |
|
|
2020
Q4 | $73.3M | Buy |
701,942
+133,878
| +24% | +$13.5M | 0.01% | 807 |
|
|
2020
Q3 | $40.2M | Sell |
568,064
-41,916
| -7% | -$2.92M | 0.01% | 989 |
|
|
2020
Q2 | $39.2M | Buy |
609,980
+268,354
| +79% | +$14.7M | 0.01% | 957 |
|
|
2020
Q1 | $10.2M | Buy |
341,626
+216,857
| +174% | +$4.99M | ﹤0.01% | 1719 |
|
|
2019
Q4 | $2.44M | Buy |
+124,769
| New | +$2.21M | ﹤0.01% | 3997 |
|
|
2019
Q3 | – | Sell |
-89,985
| Closed | -$1.33M | – | 10598 |
|
|
2019
Q2 | $1.32M | Buy |
+89,985
| New | +$1.93M | ﹤0.01% | 5070 |
|
|
2019
Q1 | – | Sell |
-25,494
| Closed | -$473K | – | 9468 |
|
|
2018
Q4 | $389K | Buy |
+25,494
| New | +$419K | ﹤0.01% | 6517 |
|
Other funds holding MRNA
TP
Jeff Yass's MRNA Position: Q2 2026 in Review
Jeff Yass increased its Moderna (MRNA) stake by 552% in Q2 2026, buying an estimated $15.7M and bringing the position to 357,774 shares worth $25.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2212.
Jeff Yass first reported a position in MRNA in Q4 2018 and has held it in 29 quarters since. The position peaked at $270M in Q3 2021. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Jeff Yass held 357,774 shares of Moderna worth $25.1M as of Q2 2026.
- Jeff Yass bought 302,934 Moderna shares in Q2 2026, an estimated $15.7M.
- Moderna made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #2212 holding.
- Jeff Yass first reported a position in Moderna in Q4 2018 and has held it in 29 quarters since.
- Jeff Yass's Moderna position peaked at $270M in Q3 2021.
- 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.